The FDA on Thursday gave license to a third dose of COVID-19 vaccine for certain citizens with weak immune systems, a narrow move into the domain of booster doses between a growing debate over their utilization.
The step will permit a third dose of both the Moderna and Pfizer-BioNTech vaccines, and applies to the immunocompromised people, constituting those with organ transplants and those “diagnosed with diseases that are said to have an equal level of immunocompromise,”
The agency asserted that the general public does not need a third dose right now.
A presentation at the CDC advisory meeting last week showed that about 2.7 percent of U.S. adults are immunocompromised.
Read More News: Click Here